Stockreport

Dogwood Therapeutics, Inc. Chief Medical Officer, Dr. Michael Gendreau, to Present an Overview of the Halneuron® Pain Research Program at the 19th Annual Pain Therapeutics Summit [Yahoo! F...

Dogwood Therapeutics, Inc.  (DWTX) 
PDF biotechnology company developing new medicines to treat pain, today announced that its Chief Medical Officer will present an overview of the Halneuron ® (tetrodotoxin) p [Read more]